B

Xiaolu Hu1, Fan Yang2, Jitao Liu3

  • 1School of Medicine, South China University of Technology, Guangzhou, China; Department of Cardiology, Guangdong Cardiovascular Institution, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

PubMed
概括

对B型内血瘤 (IMH) 的最佳医疗治疗 (BMT) 和干预治疗 (INT) 显示了类似的中期结果. INT减少了状突出 (ULP),但增加了手术风险,而 BMT需要监测ULP的进展.